Prognostication in inflammatory bowel disease

Personalized care in inflammatory bowel diseases (IBD) hinges on parsing the heterogeneity of IBD patients through prognostication of their disease course and therapeutic response to allow for tailor-made treatment and monitoring strategies to optimize care. Herein we review the currently available...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Elizabeth A., Agrawal, Manasi, Jess, Tine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582521/
https://www.ncbi.nlm.nih.gov/pubmed/36275829
http://dx.doi.org/10.3389/fmed.2022.1025375
_version_ 1784812857974587392
author Spencer, Elizabeth A.
Agrawal, Manasi
Jess, Tine
author_facet Spencer, Elizabeth A.
Agrawal, Manasi
Jess, Tine
author_sort Spencer, Elizabeth A.
collection PubMed
description Personalized care in inflammatory bowel diseases (IBD) hinges on parsing the heterogeneity of IBD patients through prognostication of their disease course and therapeutic response to allow for tailor-made treatment and monitoring strategies to optimize care. Herein we review the currently available predictors of outcomes in IBD and those on the both near and far horizons. We additionally discuss the importance of worldwide collaborative efforts and tools to support clinical use of these prognostication tools.
format Online
Article
Text
id pubmed-9582521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95825212022-10-21 Prognostication in inflammatory bowel disease Spencer, Elizabeth A. Agrawal, Manasi Jess, Tine Front Med (Lausanne) Medicine Personalized care in inflammatory bowel diseases (IBD) hinges on parsing the heterogeneity of IBD patients through prognostication of their disease course and therapeutic response to allow for tailor-made treatment and monitoring strategies to optimize care. Herein we review the currently available predictors of outcomes in IBD and those on the both near and far horizons. We additionally discuss the importance of worldwide collaborative efforts and tools to support clinical use of these prognostication tools. Frontiers Media S.A. 2022-10-06 /pmc/articles/PMC9582521/ /pubmed/36275829 http://dx.doi.org/10.3389/fmed.2022.1025375 Text en Copyright © 2022 Spencer, Agrawal and Jess. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Spencer, Elizabeth A.
Agrawal, Manasi
Jess, Tine
Prognostication in inflammatory bowel disease
title Prognostication in inflammatory bowel disease
title_full Prognostication in inflammatory bowel disease
title_fullStr Prognostication in inflammatory bowel disease
title_full_unstemmed Prognostication in inflammatory bowel disease
title_short Prognostication in inflammatory bowel disease
title_sort prognostication in inflammatory bowel disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582521/
https://www.ncbi.nlm.nih.gov/pubmed/36275829
http://dx.doi.org/10.3389/fmed.2022.1025375
work_keys_str_mv AT spencerelizabetha prognosticationininflammatoryboweldisease
AT agrawalmanasi prognosticationininflammatoryboweldisease
AT jesstine prognosticationininflammatoryboweldisease

Ejemplares similares